Tag: AMyris

3B by ’30: Big Moves by Big Players, 9 Key White House SAF Announcements and more

3B by ’30: Big Moves by Big Players, 9 Key White House SAF Announcements and more

September 9, 2021 |

  It was as busy as a mosh pit, as coordinated and fluid as Astaire and Rogers — the penny dropped on what the Unites States of America plans to do about sustainable aviation fuels, with more than a dozen companies and government agencies in the mix, as US airlines agreed to reach 3 billion […]

Read More

Amyris sees promising results for intranasal RNA/NLC vaccine

Amyris sees promising results for intranasal RNA/NLC vaccine

August 22, 2021 |

In California, Amyris, Inc. achieved promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in collaboration with the Infectious Disease Research Institute (IDRI), which means an effective Covid-19 nose spray vaccine could become reality. In-vivo results indicate that, when delivered to the mucosal membranes via intranasal administration, the Amyris/IDRI […]

Read More

Amyris did well in Q2, breaking more revenue records

Amyris did well in Q2, breaking more revenue records

August 8, 2021 |

In California, Amyris, Inc. reports another record quarter of underlying revenue, another record quarter of consumer revenue and significant gross margin expansion, and a strong cash position and robust outlook into second half 2021. “With Q2 we completed another quarter of strong strategic and operational execution,” said John Melo, President and Chief Executive Officer. “We […]

Read More

Amyris completes 1st major license for RNA COVID vaccine

Amyris completes 1st major license for RNA COVID vaccine

July 3, 2021 |

In California, Amyris, Inc. signed an exclusive license with Nant Africa, LLC relating to the development and use of the RNA COVID vaccine Amyris developed in coordination with the Infectious Disease Research Institute (IDRI). Amyris’ partnership with Nant Africa is of significant value to Amyris as it provides the fastest path to market for the […]

Read More

Amyris in $100M deal with Ingredion for Reb M sweetener

Amyris in $100M deal with Ingredion for Reb M sweetener

May 5, 2021 |

In California, Amyris, Inc. has signed an agreement with Ingredion Incorporated for the exclusive licensing of Amyris’s zero-calorie, nature-based, fermented Reb M sweetener. In addition, the agreement includes an Ingredion minority ownership stake in the Amyris Brazilian manufacturing facility that is currently under construction. The transaction value is estimated to be $100 million. This includes […]

Read More

Reese Witherspoon partners with Amyris to champion clean skincare

Reese Witherspoon partners with Amyris to champion clean skincare

April 12, 2021 |

In California, synthetic biology and renewable chemicals maker Amyris has partnered with acting powerhouse Reese Witherspoon to promote clean beauty products.  Witherspoon, whose credits include Legally Blonde and Little Big Lies, will be the global brand ambassador for Amyris’s Biossance line of sustainable skincare products.  “I have always been conscious of what’s being put on […]

Read More

Amyris partners with Minerva Foods for zero carbon protein production

Amyris partners with Minerva Foods for zero carbon protein production

April 4, 2021 |

In California, Amyris signed a memorandum of understanding for a partnership with Minerva Foods of Brazil to develop molecules for the sustainable production and distribution of animal protein. Minerva will fund Amyris’s development, scaling and production of new target molecules (with additional molecules to be identified over time), which Minerva will then be responsible for […]

Read More

Amyris signs $500M deal with DSM Nutritional Products

Amyris signs $500M deal with DSM Nutritional Products

March 31, 2021 |

In California, Amyris, Inc. has signed and closed an agreement with DSM Nutritional Products Ltd., a subsidiary of Royal DSM for the exclusive rights to supply Amyris’s product portfolio of flavor and fragrance (F&F) ingredients. Amyris will continue to develop, scale and manufacture future molecules with its existing partners and DSM. The total transaction value […]

Read More

Amyris delivers record production of CBG, utilizing 225,000 fermenters

Amyris delivers record production of CBG, utilizing 225,000 fermenters

March 28, 2021 |

In California, Amyris, Inc. achieved another breakthrough with its production of Cannabigerol (CBG) from fermentation for consumer skincare treatment formulations. Amyris believes that this production run is the largest industrial-scale fermentation-based CBG by any producer to-date. The production was completed utilizing 225,000 fermenters at the facility of Amyris’s Spain-based manufacturing partner. Amyris’s Lab-to-Market synthetic biology […]

Read More

Aquaman supports algae-based sneakers, hemp barrister wigs, mushroom leather, and more: The Digest’s Top 8 Innovations for the week of March 5th

Aquaman supports algae-based sneakers, hemp barrister wigs, mushroom leather, and more: The Digest’s Top 8 Innovations for the week of March 5th

March 4, 2021 |

Last week we had Iron Man and Bill Gates. This week it’s Aquaman’s Jason Momoa who is supporting a biobased economy with his support of algae-based sneakers. And if you thought no one was wearing barrister wigs anymore, check out the new vegan hemp wigs instead of traditional horsehair for UK’s barristers, who yes, apparently […]

Read More